Dupuis C - Search Results

1

[Observance and results of concurrent chemoradiotherapy after induction chemotherapy by docetaxel, cisplatin and 5-fluoro-uracil for locally advanced head and neck cancers].

Calderon B, Guerder C, Resbeut M, Fakhry N, Dupuis C, Cowen D. Calderon B, et al. Among authors: dupuis c. Cancer Radiother. 2016 Apr;20(2):83-90. doi: 10.1016/j.canrad.2015.10.001. Epub 2016 Mar 8. Cancer Radiother. 2016. PMID: 26969244 French.

2

Cetuximab combined with paclitaxel or paclitaxel alone for patients with recurrent or metastatic head and neck squamous cell carcinoma progressing after EXTREME.

Chevalier T, Daste A, Saada-Bouzid E, Loundou A, Peyraud F, Lambert T, Le Tourneau C, Peyrade F, Dupuis C, Alfonsi M, Fayette J, Reure J, Huguet F, Fakhry N, Toullec C, Salas S. Chevalier T, et al. Among authors: dupuis c. Cancer Med. 2021 Jun;10(12):3952-3963. doi: 10.1002/cam4.3953. Epub 2021 May 25. Cancer Med. 2021. PMID: 34080776 Free PMC article.

3

A simple and rapid LC-MS/MS method for therapeutic drug monitoring of cetuximab: a GPCO-UNICANCER proof of concept study in head-and-neck cancer patients.

Becher F, Ciccolini J, Imbs DC, Marin C, Fournel C, Dupuis C, Fakhry N, Pourroy B, Ghettas A, Pruvost A, Junot C, Duffaud F, Lacarelle B, Salas S. Becher F, et al. Among authors: dupuis c. Sci Rep. 2017 Jun 2;7(1):2714. doi: 10.1038/s41598-017-02821-x. Sci Rep. 2017. PMID: 28578404 Free PMC article.

4

UPFRONT DPD DEFICIENCY DETECTION TO SECURE 5-FU ADMINISTRATION: PART 2- APPLICATION TO HEAD-AND-NECK CANCER PATIENTS.

Launay M, Ciccolini J, Fournel C, Blanquicett C, Dupuis C, Fakhry N, Duffaud F, Salas S, Lacarelle B. Launay M, et al. Among authors: dupuis c. Clin Cancer Drugs. 2017;4(2):122-128. doi: 10.2174/2212697x04666170817123425. Clin Cancer Drugs. 2017. PMID: 29682445 Free PMC article.

5

Therapeutic drug monitoring for dose individualization of Cisplatin in testicular cancer patients based upon total platinum measurement in plasma.

Salas S, Mercier C, Ciccolini J, Pourroy B, Fanciullino R, Tranchand B, Monjanel-Mouterde S, Baciuchka-Palmaro M, Dupuis C, Yang C, Balti M, Lacarelle B, Duffaud F, Durand A, Favre R. Salas S, et al. Among authors: dupuis c. Ther Drug Monit. 2006 Aug;28(4):532-9. doi: 10.1097/00007691-200608000-00008. Ther Drug Monit. 2006. PMID: 16885721 Clinical Trial.

6

Early severe toxicities after capecitabine intake: possible implication of a cytidine deaminase extensive metabolizer profile.

Mercier C, Dupuis C, Blesius A, Fanciullino R, Yang CG, Padovani L, Giacometti S, Frances N, Iliadis A, Duffaud F, Ciccolini J. Mercier C, et al. Among authors: dupuis c. Cancer Chemother Pharmacol. 2009 May;63(6):1177-80. doi: 10.1007/s00280-008-0889-1. Epub 2008 Dec 24. Cancer Chemother Pharmacol. 2009. PMID: 19107485

7

High-dose methotrexate in adults with osteosarcoma: a population pharmacokinetics study and validation of a new limited sampling strategy.

Dupuis C, Mercier C, Yang C, Monjanel-Mouterde S, Ciccolini J, Fanciullino R, Pourroy B, Deville JL, Duffaud F, Bagarry-Liegey D, Durand A, Iliadis A, Favre R. Dupuis C, et al. Anticancer Drugs. 2008 Mar;19(3):267-73. doi: 10.1097/cad.0b013e3282f21376. Anticancer Drugs. 2008. PMID: 18510172

8

Toxic death case in a patient undergoing gemcitabine-based chemotherapy in relation with cytidine deaminase downregulation.

Mercier C, Raynal C, Dahan L, Ortiz A, Evrard A, Dupuis C, Blesius A, Duluc M, Franceschini F, Giacometti S, Salas S, Milano G, Favre R, Seitz JF, Ciccolini J. Mercier C, et al. Among authors: dupuis c. Pharmacogenet Genomics. 2007 Oct;17(10):841-4. doi: 10.1097/FPC.0b013e32825ea6e3. Pharmacogenet Genomics. 2007. PMID: 17885621

9

Paravertebral Well-Differentiated Liposarcoma with Low-Grade Osteosarcomatous Component: Case Report with 11-Year Follow-Up, Radiological, Pathological, and Genetic Data, and Literature Review.

Macagno N, Fuentes S, de Pinieux G, Maues de Paula A, Salas S, Mattéi JC, Dupuis C, Appay R, Aurias A, Dufour H, Figarella-Branger D, Bouvier C. Macagno N, et al. Among authors: dupuis c. Case Rep Pathol. 2017;2017:2346316. doi: 10.1155/2017/2346316. Epub 2017 Mar 9. Case Rep Pathol. 2017. PMID: 28377828 Free PMC article.

10

Functional evidence for NO-synthase activation by substance P through a mechanism not involving classical tachykinin receptors in guinea-pig ileum in vitro.

Garcia-Villar R, Dupuis C, Martinolle JP, Fioramonti J, Buéno L. Garcia-Villar R, et al. Among authors: dupuis c. Br J Pharmacol. 1996 Jul;118(5):1253-61. doi: 10.1111/j.1476-5381.1996.tb15531.x. Br J Pharmacol. 1996. PMID: 8818351 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

450 results

Search Page

Filters